DOI: 10.1128/JVI.02472-16
Article Information
PubMed
Published By
History
- Received December 23, 2016
- Accepted February 1, 2017
- Published online March 29, 2017.
Copyright & Usage
Copyright © 2017 American Society for Microbiology.
All Rights Reserved
.
Editors and / or Reviewers
- Terence S. Dermody, Editor, University of Pittsburgh School of Medicine
Article Versions
- Accepted Manuscript version (February 08, 2017).
- You are viewing the most recent version of this article.
Author Information
- Kelly Wattersa,
- Bahar Inankurb*,
- Jaye C. Gardinera,d,
- Jay Warrickc,
- Nathan M. Sherera,d,
- John Yinb and
- Ann C. Palmenberga,e
- aInstitute for Molecular Virology, University of Wisconsin—Madison, Madison, Wisconsin, USA
- bWisconsin Institutes for Discovery and Department of Chemical and Biological Engineering, University of Wisconsin—Madison, Madison, Wisconsin, USA
- cWisconsin Institutes for Medical Research and Department of Biomedical Engineering, University of Wisconsin—Madison, Madison, Wisconsin, USA
- dMcArdle Laboratories for Cancer Research, University of Wisconsin—Madison, Madison, Wisconsin, USA
- eDepartment of Biochemistry, University of Wisconsin—Madison, Madison, Wisconsin, USA
- Address correspondence to Ann C. Palmenberg, acpalmen{at}wisc.edu.
Citation Watters K, Inankur B, Gardiner JC, Warrick J, Sherer NM, Yin J, Palmenberg AC. 2017. Differential disruption of nucleocytoplasmic trafficking pathways by rhinovirus 2A proteases. J Virol 91:e02472-16. https://doi.org/10.1128/JVI.02472-16 .
↵* Present address: Bahar Inankur, Bristol-Myers Squibb, New Brunswick, New Jersey, USA.
